IFIH1 and Aicardi-Goutieres syndrome: Thus, to identify new therapeutic targets for AGS and interferonopathies, we conducted an extensive analysis of these iPSC-derived DCs with the IFIH1 R779H mutation, particularly through RNA sequencing.